Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.93 Million CNY | -90.46% |
| 2022 | 20.32 Million CNY | -25.97% |
| 2021 | 27.45 Million CNY | 1659.75% |
| 2020 | 1.56 Million CNY | 5.43% |
| 2019 | 1.47 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - CNY | -100.0% |
| 2024 Q2 | - CNY | 0.0% |
| 2023 Q2 | 16.59 Million CNY | 121.13% |
| 2023 FY | 1.93 Million CNY | -90.46% |
| 2023 Q1 | 7.5 Million CNY | -63.08% |
| 2023 Q3 | 183 Thousand CNY | -98.9% |
| 2023 Q4 | 1.93 Million CNY | 960.09% |
| 2022 Q2 | 24.97 Million HKD | 0.0% |
| 2022 FY | 20.32 Million CNY | -25.97% |
| 2022 Q4 | 20.32 Million CNY | 93.8% |
| 2022 Q3 | 10.48 Million CNY | -58.0% |
| 2021 Q4 | 27.45 Million HKD | 0.0% |
| 2021 FY | 27.45 Million CNY | 1659.75% |
| 2020 FY | 1.56 Million CNY | 5.43% |
| 2019 FY | 1.47 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | 96.33% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 99.967% |